key: cord-0710829-u23957a5
authors: Chaudhry, Sunit-Preet; Salerno, Christopher T.; Ravichandran, Ashwin K.; Walsh, Mary Norine
title: Shared Decision Making in Cardiac Transplantation during the COVID19 Pandemic: Patient Refusal of Transplantation
date: 2020-06-08
journal: JACC Case Rep
DOI: 10.1016/j.jaccas.2020.06.004
sha: 4dab6a00374172494925111a1852fd426d59c4f5
doc_id: 710829
cord_uid: u23957a5

Abstract SDM with advanced heart failure patients is critical in making decisions regarding therapies such as LVAD and cardiac transplantation. We describe a case wherein the risks of COVID19 infection affected the decision of a patient around proceeding with cardiac transplantation.

Introduction SDM with advanced heart failure patients focuses on prognosis, patient values, and preferences (1) . For patients listed for cardiac transplantation, SDM around donor selection involves the mandated disclosure of donor characteristics that may increase infectious risks (2) (3) (4) (5) . During the ongoing COVID19 pandemic, more extensive discussion around COVID19 specific infectious risk is necessary, as well as disclosure of increased recipient risk due to hospital admission (in the case that the recipient is an outpatient) and immunosuppression following transplantation. We describe a case of patient refusal of transplantation solely due to concerns about COVID19.

A 68-year-old man with dilated cardiomyopathy who failed guideline directed medical therapy was implanted with a HeartMate III LVAD in January 2019 as a bridge to transplantation. His early post LVAD course was unremarkable, and after recovery from surgery and completion of cardiac rehab, his transplant evaluation was completed. The option of accepting "high-risk hearts" and hepatitis C donors was discussed; he declined these options and was listed as a UNOS Status 4 patient in October 2019. As time on LVAD support continued, he developed complications, including recurrent gastrointestinal hemorrhage and ventricular arrhythmias. These complications increased the urgency of the need for transplantation. Due to his concerns of further LVAD-related complications as well as an increasing concern of death, he requested possible options to increase his probability of receiving a donor heart in an expedited time frame. "High-risk" and hepatitis C donors, as well as possible participation in a clinical trial evaluating the safety and efficacy of an organ care system to assess donor hearts that do not meet the current standard donor heart acceptance criteria 6 were again discussed, and he consented to all options.

In the wake of the COVID19 pandemic, because of potential increased risk to transplant recipients, our program made the decision to review donor offers only for United Network of Organ Sharing (UNOS) Status 1-3 patients and select UNOS Status 4 patients. After discussion of risks, benefits, and alternatives of such an approach, the patient agreed to remain listed for transplantation.

His past medical history was notable for type 2 diabetes mellitus, remote prostate cancer, and ventricular tachycardia.

On 5/1/2020, a donor became available and the patient was contacted by the transplant surgeon. He was screened for symptoms of COVID19 and possible exposure. He denied symptoms and verified that he had been at home without exposure to anyone who was ill. He was than informed that a suitable donor (who tested negative for COVID19) was identified, and that while the exact risks of transplant during the pandemic are unknown, with his medical complications on LVAD support the survival benefits of transplant in his case likely outweighed the risk of COVID19 during the current pandemic. He asked for further clarification and was informed that we had successfully performed two transplants during this era without any COVID19 related adverse events, and that his transplantation would be at a COVID19 free hospital (7), although there was still theoretically a greater chance of exposure to COVID-19 at the hospital than at home. He had concerns about being transplanted in a facility that he had never been to and was particularly uncertain about moving forward when he was told that the hospital had a policy of no visitation during the pandemic.

The patient ultimately declined the organ citing concerns over possible COVID infection, isolation from his family due to a restricted visitor policy and a preference to wait until the pandemic had "settled down". He asked if he would lose his "spot" on the list and was reassured that he would remain listed. He again expressed fear of contracting COVID and concern of a prolonged separation from his family. 1. To describe the importance of SDM for patients with advanced heart failure.

2. To highlight that outcomes, other than survival, are important to patients awaiting cardiac transplantation.

3. To emphasize the need for ongoing discussion with patients regarding individual risks during the COVID 19 pandemic.

Decision making in advanced heart failure: a scientific statement from the American Heart Association

Informing candidates for solid-organ transplantation about donor risk factors. The New England journal of medicine

United States Public Health S. PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public health reports

Disclosure of infectious risk to heart transplant candidates: Shared decision-making is here to stay. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation